OpenURL Connection Search

Select item for more details and to access through your institution.

Observational study on the therapeutic management and economic burden of adult patients with moderate to severe plaque psoriasis in France - the POP study.
Published in:
Journal of Market Access & Health Policy, 2023, v. 11, n. 1, p. 1, doi. 10.1080/20016689.2023.2270293
By:
- Villani, A. P.;
- Tsimaratos, N. Quiles;
- Crochard, A.;
- Gherardi, A.;
- Panes, A.;
- Schmidt, A.;
- Kollen, M. Hueber;
- Borget, I.
Publication type:
Article
Janus kinase inhibitors for the treatment of atopic dermatitis: Real‐life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee recommended measures.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2023, v. 37, n. 11, p. e1307, doi. 10.1111/jdv.19302
By:
- Reguiai, Z.;
- Becherel, P. A.;
- Fougerousse, A. C.;
- Chaby, G.;
- Perrot, J. L.;
- Begon, E.;
- Jacobzone‐Lévêque, C.;
- Boulard, C.;
- Badaoui, A.;
- Poreaux, C.;
- David, L.;
- Quiles‐Tsimaratos, N.;
- Lons‐Danic, D.;
- Fite, C.;
- Liegeon, A.‐L.;
- Patchinsky, A.;
- Parier, J.;
- Garcia, C.;
- Estève, E.;
- Mohty, R.
Publication type:
Article
Tattoo complications in treated and non‐treated psoriatic patients.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2020, v. 34, n. 4, p. 888, doi. 10.1111/jdv.15975
By:
- Grodner, C.;
- Beauchet, A.;
- Fougerousse, A.‐C.;
- Quiles‐Tsimaratos, N.;
- Perrot, J.‐L.;
- Barthelemy, H.;
- Parier, J.;
- Maccari, F.;
- Beneton, N.;
- Bouilly‐Auvray, D.;
- Ruer‐Mulard, M.;
- Boulard, C.;
- Jacobzone, C.;
- Thomas‐Beaulieu, D.;
- Pourchot, D.;
- Méry‐Bossard, L.;
- Chaby, G.;
- Girard, C.;
- Duval‐Modeste, A.‐B.;
- Vermersch‐Langlin, A.
Publication type:
Article
Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real‐world clinical setting.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2019, v. 33, n. 12, p. e476, doi. 10.1111/jdv.15804
By:
- Fougerousse, A.‐C.;
- Maccari, F.;
- Beauchet, A.;
- Parier, J.;
- Boulard, C.;
- Becherel, P.‐A.;
- Quiles‐Tsimaratos, N.;
- Le Guyadec, T.;
- Thomas‐Beaulieu, D.;
- Halioua, B.;
- Begon, E.;
- Bastien, M.;
- Perrot, J.‐L.;
- Pallure, V.;
- Bilan, P.;
- Steff, M.;
- Pfister, P.;
- Vermersch‐Langlin, A.;
- Boyé, T.;
- Mery‐Bossard, L.
Publication type:
Article
Tattooing and psoriasis: dermatologists' knowledge, attitudes and practices. An international study.
Published in:
2019
By:
- Grodner, C.;
- Mahé, E.;
- Kluger, N.;
- Fougerousse, A.‐C.;
- Cinotti, E.;
- Lacarrubba, F.;
- Quiles‐Tsimaratos, N.
Publication type:
Letter to the Editor
Characteristics of patients with plaque psoriasis who have discordance between Psoriasis Area Severity Index and dermatology life quality index scores.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2017, v. 31, n. 5, p. e269, doi. 10.1111/jdv.14021
By:
- Amy de la Breteque, M.;
- Beauchet, A.;
- Quiles ‐ Tsimaratos, N.;
- Estève, E.;
- Le Guyadec, T.;
- Ruer ‐ Mulard, M.;
- Maccari, F.;
- Reguiai, Z.;
- Girard, C.;
- Bastien, M.;
- Avenel ‐ Audran, M.;
- Pauwels, C.;
- Bouilly ‐ Auvray, D.;
- Sigal, M. ‐ L.;
- Mahé, E.
Publication type:
Article
Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study.
Published in:
Journal of the European Academy of Dermatology & Venereology, 2014, v. 28, n. 2, p. 151, doi. 10.1111/jdv.12066
By:
- Mahé, E.;
- Reguiai, Z.;
- Barthelemy, H.;
- Quiles ‐ Tsimaratos, N.;
- Chaby, G.;
- Girard, C.;
- Estève, E.;
- Maccari, F.;
- Descamps, V.;
- Schmutz, J. ‐ L.;
- Begon, E.;
- Bravard, P.;
- Maillard, H.;
- Boyé, T.;
- Beauchet, A.;
- Sigal, M. ‐ L.
Publication type:
Article

Found: 7

Observational study on the therapeutic management and economic burden of adult patients with moderate to severe plaque psoriasis in France - the POP study.

Janus kinase inhibitors for the treatment of atopic dermatitis: Real‐life data on efficacy and safety in light of the Pharmacovigilance Risk Assessment Committee recommended measures.

Tattoo complications in treated and non‐treated psoriatic patients.

Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real‐world clinical setting.

Tattooing and psoriasis: dermatologists' knowledge, attitudes and practices. An international study.

Characteristics of patients with plaque psoriasis who have discordance between Psoriasis Area Severity Index and dermatology life quality index scores.

Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study.